Related Books
Language: en
Pages: 222
Pages: 222
Type: BOOK - Published: 2013-11-27 - Publisher: CRC Press
Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development
Language: en
Pages: 98
Pages: 98
Type: BOOK - Published: 2007-09-14 - Publisher: National Academies Press
All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a
Language: en
Pages: 123
Pages: 123
Type: BOOK - Published: 2014-12-19 - Publisher: National Academies Press
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying
Language: en
Pages: 296
Pages: 296
Type: BOOK - Published: 2017-12-19 - Publisher: CRC Press
Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and
Language: en
Pages: 304
Pages: 304
Type: BOOK - Published: 2009-08-04 - Publisher: John Wiley & Sons
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to bal